801 West Biotech Opportunity Series 1
801 West Biotech Opportunity Series 1 is a hedge fund based in Lake Oswego, Oregon. According to its most recent Form D, filed Aug 13, 2026, the fund has sold $56,885,000 of interests to 27 investors since its first sale in Aug 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include 801 West Capital Management, LLC; Corey Von Allmen; Jonathan McGowan.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $56,885,000Cumulative sales reported on Form D
- Investors
- 27
- First sale
- Aug 1, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- 801 West Capital Management, LLC; Corey Von Allmen; Jonathan McGowan
- Latest Form D
- Aug 13, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures
Size compared with every hedge fund
Raised more than 50% of the 16 hedge funds based in Oregon, and more than 48% of all 10,157 that report sales.